Topics

Lung Cancer
'Liquid biopsy' picks up cancer biomarkers in blood, study finds
'Liquid biopsy' picks up cancer biomarkers in blood, study finds

A blood test known as a "liquid biopsy" could help doctors track a shifty type of lung cancer without the need for invasive procedures, an international team of researchers says. The findings, presented at the American Assn. for Cancer Research meeting taking place in Philadelphia, could help doctors predict whether patients with non-small cell lung cancer will respond to treatment with the drug crizotinib. The results also lend further support to the idea that, in many cases, non-invasive blood tests may be able to detect cancer biomarkers as effectively as traditional biopsies. Non-small cell lung cancers make up about 85% to 90% of lung cancers, according to the American...

Loading